Nasdaq Markets

Pfizer's coronavirus vaccine could be a game-changer. The pharmaceutical company's announcement that the vaccine has been more than 90% effective in early trials is shaking up the stock market's dynamics and pointing toward the potential for some companies to go on explosive runs

The stock market can be unpredictable, changing so fast that it leaves investors' heads spinning. But the long-term investor knows that the best way to build wealth is to focus on companies with solid underlying fundamentals and a robust core business that aligns with their perso

The apparel industry has seen rapid change in 2020 due to the coronavirus pandemic. Revolve Group (NYSE: RVLV), an online-only retailer focused on fashion apparel for millennial women, is feeling the best and worst of this change. Demand for the company's products has declined th

On Election Day, majorities of voters in New Jersey, Arizona, South Dakota, and Montana cast their ballots to legalize recreational marijuana. That brings the number of states in which adult-use cannabis is legal to 15 states plus Washington, D.C. Another 20 states have legalized

Boston Omaha Corporation (NASDAQ: BOMN) is often compared to an early stage version of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B). And like Berkshire, Boston Omaha prefers to pursue investment opportunities that have excellent risk-reward dynamics.Unlike Berkshire, however, Bo

Pfizer's Nov. 9 announcement that it's making progress toward a COVID-19 vaccine caused markets to rally, with beaten down sectors including airlines, industrials, and retailers leading the way higher.It's way too soon to declare the pandemic over, but hopefully with a vaccine on

The world woke up to a pleasant surprise on Monday morning as pharmaceutical giant Pfizer announced positive data for its COVID-19 vaccine candidate. That news fueled a massive rally in the market, especially shares of companies most impacted by the pandemic, like oil stocks. How

This is an important month for coronavirus stocks. Ten coronavirus vaccine programs are in phase 3 trials, and some companies may even apply for emergency use authorization (EUA) in the coming weeks. That means we might soon know the winners of this much-watched race to be the fi

The year 2020 has been full of surprises. Growth stocks, which are usually the first to get battered during economic downturns, have performed exceptionally well, while many stable and mature companies have been poor performers.Historically, Johnson & Johnson (NYSE: JNJ) has

The Dividend Aristocrat index is an elite group of stocks. To be considered for membership, a publicly traded company must establish a 25-year track record of consecutive dividend increases. Even some of the best dividend stocks don't get to this point -- recessions, pandemics, a

Key Points This biotech company stands out with its plan for post-pandemic prevention. It could lead when it comes to production capacity and logistics. Management expects to report interim phase 3 data for its coronavirus vaccine candidate early next year. Our experts issued

Image source: Getty Images

When the COVID-19 pandemic shook the world this year, investors didn't follow the typical playbook for declining markets.Ordinarily, money would flow to investments perceived as lower risk: bonds, dividend stocks, or "value" stocks selling at low multiples of sales, earnings, or

Successful investing does not need to involve taking excessive amounts of risk. There are plenty of companies offering shareholders compelling upside without extreme risk and volatility.Here we will explore three low-risk investment opportunities to bolster your portfolio.

When the curtain closes on 2020 in less than seven weeks, it's bound to go down as one of the most volatile years on record for Wall Street.For instance, the 124-year-old Dow Jones Industrial Average registered 14 of its 16 largest single-day point declines in history this year,

Fool.com's Healthcare and Cannabis Bureau Chief Corinne Cardina interviewed Richard Horton on Motley Fool Live on Oct. 9. Horton runs the British medical journal The Lancet and has been at the forefront of publishing data about the coronavirus pandemic this year. He also recently

Choosing the best biotech stocks can sometimes seem like gambling. Trying to figure out which company's drug candidates are more likely to work, or whether your ownership stake will get diluted as the company tries to secure funding to keep a trial going, can often feel like a gu

Fool.com's Healthcare and Cannabis Bureau Chief Corinne Cardina interviewed Richard Horton on Motley Fool Live on Oct. 9. Horton runs the British medical journal The Lancet and has been at the forefront of publishing data about the coronavirus pandemic this year. He also recently

Inovio Pharmaceuticals (NASDAQ: INO) and Regeneron Pharmaceuticals (NASDAQ: REGN) are both deeply involved in making medicines to fight against COVID-19, but the similarities end there. Inovio is a clinical-stage biotech, hoping to utilize its DNA-based vaccine technology to prod

(RTTNews) - General Motors said that it will recall 2017-2019 model-year Chevrolet Bolt electric vehicles with high voltage batteries produced at LG Chem's Ochang, South Korea facility that may pose a risk of fire when charged to full, or very close to full, capacity.The company